Neuroone Medical Technologies (NMTC) Cash & Equivalents (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.11% |
| Dec 31, 2025 | -45.21% |
| Sep 30, 2025 | -18.28% |
| Jun 30, 2025 | 508.95% |
| Mar 31, 2025 | 16.39% |
| Dec 31, 2024 | -22.31% |
| Sep 30, 2024 | -9.87% |
| Jun 30, 2024 | -33.46% |
| Mar 31, 2024 | -9.19% |
| Dec 31, 2023 | -49.63% |
| Sep 30, 2023 | 72.61% |
| Jun 30, 2023 | -14.40% |
| Mar 31, 2023 | -22.82% |
| Dec 31, 2022 | -42.80% |
| Sep 30, 2022 | -19.83% |
| Jun 30, 2022 | -20.91% |
| Mar 31, 2022 | -20.48% |
| Dec 31, 2021 | 134.51% |
| Sep 30, 2021 | -23.24% |
| Jun 30, 2021 | -20.25% |
| Mar 31, 2021 | 58.14% |
| Dec 31, 2020 | 76.62% |
| Sep 30, 2020 | 5.56% |
| Jun 30, 2020 | 411.74% |
| Mar 31, 2020 | -63.45% |
| Dec 31, 2019 | 684.01% |
| Sep 30, 2019 | -79.09% |
| Jun 30, 2019 | -45.92% |
| Mar 31, 2019 | 557.60% |
| Dec 31, 2018 | 2,543.86% |
| Sep 30, 2018 | -41.35% |
| Jun 30, 2018 | -10.28% |
| Mar 31, 2018 | -4.79% |
| Dec 31, 2017 | -62.21% |